Jincai S. Wu
Haikou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: October 12, 2024
Palliative radiotherapy for hepatic cancer pain.
Journal: The Lancet. Oncology
Published: October 08, 2024
A Novel RNA Methylation-Related Prognostic Signature and its Tumor Microenvironment Characterization in Hepatocellular Carcinoma.
Journal: Technology in cancer research & treatment
Published: August 19, 2024
Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
Journal: The British journal of surgery
Published: May 24, 2024
A commentary on 'Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer - an in-depth quantitative evaluation and retrospective cohort analysis'.
Journal: International journal of surgery (London, England)
Published: March 26, 2024
Prognostic value of oxidative phosphorylation-related genes in hepatocellular carcinoma.
Journal: Discover oncology
Published: March 10, 2024
Prognostic value and gene regulatory network of CMSS1 in hepatocellular carcinoma.
Journal: Cancer biomarkers : section A of Disease markers
Published: December 31, 2023
DERL2 (derlin 2) stabilizes BAG6 (BAG cochaperone 6) in chemotherapy resistance of cholangiocarcinoma.
Journal: Journal of physiology and biochemistry
Published: April 01, 2023
Coagulation Dysfunction in Patients with Liver Cirrhosis and Splenomegaly and Its Countermeasures: A Retrospective Study of 1522 Patients.
Journal: Disease markers
Published: March 08, 2023
Secukinumab plays a synergistic role with starvation therapy in promoting autophagic cell death of hepatocellular carcinoma via inhibiting IL-17A-increased BCL2 level.
Journal: In vitro cellular & developmental biology. Animal
Published: January 30, 2023
Correction to: ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway.
Journal: Cell death & disease
Published: March 03, 2022
Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma.
Journal: Liver cancer
Published: February 22, 2022
Last Updated: 09/26/2026